NASDAQ:TRNS - Transcat Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$20.85 +0.25 (+1.21 %)
(As of 06/20/2018 05:50 AM ET)
Previous Close$20.60
Today's Range$20.15 - $20.85
52-Week Range$11.95 - $21.10
Volume14,500 shs
Average Volume15,982 shs
Market Capitalization$144.67 million
P/E Ratio29.01
Dividend YieldN/A
Beta0.42
Transcat logoTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to integrate and manage the workflow of its calibration service centers and customers' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as an off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment distributes approximately 100,000 test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.

Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Instruments to measure electricity
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:TRNS
CUSIPN/A
Phone585-352-7777

Debt

Debt-to-Equity Ratio0.40
Current Ratio1.92
Quick Ratio1.32

Price-To-Earnings

Trailing P/E Ratio29.01
Forward P/E Ratio22.42
P/E Growth2.7

Sales & Book Value

Annual Sales$155.14 million
Price / Sales0.97
Cash Flow$1.6213 per share
Price / Cash12.86
Book Value$7.18 per share
Price / Book2.90

Profitability

EPS (Most Recent Fiscal Year)$0.71
Net Income$5.92 million
Net Margins3.82%
Return on Equity10.83%
Return on Assets5.49%

Miscellaneous

Employees606
Outstanding Shares7,200,000

Transcat (NASDAQ:TRNS) Frequently Asked Questions

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) released its earnings results on Wednesday, May, 23rd. The scientific and technical instruments company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.23 by $0.04. The scientific and technical instruments company had revenue of $42.45 million for the quarter, compared to the consensus estimate of $40.70 million. Transcat had a net margin of 3.82% and a return on equity of 10.83%. View Transcat's Earnings History.

What price target have analysts set for TRNS?

3 brokers have issued 1 year price objectives for Transcat's shares. Their forecasts range from $20.00 to $20.00. On average, they anticipate Transcat's share price to reach $20.00 in the next twelve months. View Analyst Ratings for Transcat.

Who are some of Transcat's key competitors?

Who are Transcat's key executives?

Transcat's management team includes the folowing people:
  • Mr. Lee D. Rudow, Pres, CEO & Director (Age 54)
  • Mr. Michael J Tschiderer, VP of Fin., CFO, Treasurer & Corp. Sec. (Age 58)
  • Mr. Robert A. Flack, VP of Service Sales & Operations (Age 48)
  • Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 52)
  • Mr. Michael W. West, VP of Marketing & Inside Sales (Age 47)

Has Transcat been receiving favorable news coverage?

Headlines about TRNS stock have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Transcat earned a media sentiment score of 0.24 on Accern's scale. They also assigned news stories about the scientific and technical instruments company an impact score of 46.50 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Transcat's major shareholders?

Transcat's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (4.42%), WCM Investment Management CA (4.22%), Polar Asset Management Partners Inc. (3.47%), Dalton Greiner Hartman Maher & Co. (3.10%), Neuberger Berman Group LLC (1.87%) and Quantum Capital Management (1.17%). Company insiders that own Transcat stock include Alan H Resnick, Angela J Panzarella, Carl E Sassano, Charles P Hadeed, John T Smith, Michael Tschiderer, Paul D Moore and Robert A Flack. View Institutional Ownership Trends for Transcat.

Which major investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Dalton Greiner Hartman Maher & Co., QCI Asset Management Inc. NY and Neuberger Berman Group LLC. Company insiders that have sold Transcat company stock in the last year include Alan H Resnick, Carl E Sassano, Charles P Hadeed, John T Smith and Paul D Moore. View Insider Buying and Selling for Transcat.

Which major investors are buying Transcat stock?

TRNS stock was purchased by a variety of institutional investors in the last quarter, including Polar Asset Management Partners Inc., UBS Group AG, Segall Bryant & Hamill LLC, Quantum Capital Management, Hancock Holding Co., Dimensional Fund Advisors LP and ZPR Investment Management. Company insiders that have bought Transcat stock in the last two years include Angela J Panzarella, Michael Tschiderer and Robert A Flack. View Insider Buying and Selling for Transcat.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $20.85.

How big of a company is Transcat?

Transcat has a market capitalization of $144.67 million and generates $155.14 million in revenue each year. The scientific and technical instruments company earns $5.92 million in net income (profit) each year or $0.71 on an earnings per share basis. Transcat employs 606 workers across the globe.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected]


MarketBeat Community Rating for Transcat (TRNS)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  153
MarketBeat's community ratings are surveys of what our community members think about Transcat and other stocks. Vote "Outperform" if you believe TRNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.